These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years. Ferraccioli GF; Gremese E; Tomietto P; Favret G; Damato R; Di Poi E Rheumatology (Oxford); 2002 Aug; 41(8):892-8. PubMed ID: 12154206 [TBL] [Abstract][Full Text] [Related]
24. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine. Farr M; Symmons DP; Bacon PA Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931 [TBL] [Abstract][Full Text] [Related]
25. [Assessment of sulfasalazine and hydroxichloroqine hepatotoxicity in patients with rheumatic arthritis and isolated HBS-antigen positivity]. Petrov AV Lik Sprava; 2004; (1):60-5. PubMed ID: 17051718 [TBL] [Abstract][Full Text] [Related]
26. Cyclosporin for sulphasalazine-induced aplastic anaemia in a patient with early rheumatoid arthritis. Nurmohamed MT; Soesan M; van Oers MH; Dijkmans BA; van Soesbergen RM Rheumatology (Oxford); 2000 Dec; 39(12):1431-3. PubMed ID: 11136894 [No Abstract] [Full Text] [Related]
27. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis. van Riel PL; van Gestel AM; van de Putte LB Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648 [TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment. van Rossum MA; van Soesbergen RM; Boers M; Zwinderman AH; Fiselier TJ; Franssen MJ; ten Cate R; van Suijlekom-Smit LW; Wulffraat NM; van Luijk WH; Oostveen JC; Kuis W; Dijkmans BA; Ann Rheum Dis; 2007 Nov; 66(11):1518-24. PubMed ID: 17491099 [TBL] [Abstract][Full Text] [Related]
29. Abrupt occurrence of high fever and rash in a patient treated with sulphasalazine for psoriatic arthritis. Fischetti F; Gerloni R; Bardelli M; Carretta R Minerva Med; 2003 Dec; 94(6):437-44. PubMed ID: 14976471 [TBL] [Abstract][Full Text] [Related]
30. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study. Lee HJ; Waller RD; Stebbings S; Highton J; Orlovich DA; Schmierer D; Fawcett JP Int J Rheum Dis; 2010 Feb; 13(1):48-54. PubMed ID: 20374384 [TBL] [Abstract][Full Text] [Related]
31. Sulphasalazine in the treatment of children with chronic arthritis. Huang JL; Chen LC Clin Rheumatol; 1998; 17(5):359-63. PubMed ID: 9805178 [TBL] [Abstract][Full Text] [Related]
32. [Sulfasalazine neurotoxicity]. Chadenat ML; Morelon S; Dupont C; Dechy H; Raffin-Sanson ML; Dorra M; Rouveix E Ann Med Interne (Paris); 2001 Jun; 152(4):283-4. PubMed ID: 11474379 [TBL] [Abstract][Full Text] [Related]
33. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Clegg DO; Reda DJ; Abdellatif M Arthritis Rheum; 1999 Nov; 42(11):2325-9. PubMed ID: 10555027 [TBL] [Abstract][Full Text] [Related]
34. [Life-threatening liver failure and severe dyscrasias in blood and lymph nodes caused by sulphasalazine]. Kampmann P; Højlyng N; Pedersen M Ugeskr Laeger; 2006 Sep; 168(39):3331-3. PubMed ID: 17032600 [TBL] [Abstract][Full Text] [Related]
35. [Toxic epidermal necrolysis during therapy with sulphasalazine in a patient with arthritis. Case report]. Rachwał-Siek K; Ponikowska M; Wiland P Wiad Lek; 2011; 64(4):283-7. PubMed ID: 22533153 [TBL] [Abstract][Full Text] [Related]
36. Use of sulfasalazine in rheumatic diseases. Fuchs HA Bull Rheum Dis; 1997 Nov; 46(7):3-4. PubMed ID: 9366125 [No Abstract] [Full Text] [Related]